Nanoco Group plc (NNOCF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Nanoco Group plc (NNOCF) with AI Score 48/100 (Weak). Nanoco Group plc researches, develops, manufactures, and licenses nanomaterials for commercial applications. Market cap: 0, Sector: Technology.
Last analyzed: Mar 17, 2026Nanoco Group plc (NNOCF) Technology Profile & Competitive Position
Nanoco Group plc specializes in developing and manufacturing quantum dots for various applications, including displays, sensors, and medical imaging. With a global presence and a focus on advanced nanomaterials, Nanoco operates in the competitive semiconductor industry, licensing its technology to diverse markets.
Investment Thesis
Nanoco Group plc presents a speculative investment opportunity within the nanomaterials sector. The company's focus on quantum dots for display and sensor applications offers potential for growth, driven by increasing demand for advanced display technologies and sensor solutions. With a market capitalization of $0.01 billion and negative P/E ratio of -4.83, the company's financial performance reflects its current stage of development. Key value drivers include successful licensing agreements and expansion into new markets. Ongoing catalysts include potential partnerships and advancements in quantum dot technology. Potential risks include competition from established players and the need for continued innovation to maintain a competitive edge.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.01 billion, reflecting its small-cap status.
- Negative P/E ratio of -4.83, indicating current losses.
- Gross margin of 73.9%, showcasing strong pricing power in its niche market.
- Profit margin of -28.8%, highlighting the need for improved operational efficiency.
- Beta of -0.01, suggesting low volatility compared to the market.
Competitors & Peers
Strengths
- Proprietary quantum dot technology.
- Strong patent portfolio.
- Global presence and operations.
- Diverse applications across multiple industries.
Weaknesses
- Negative profitability.
- Small market capitalization.
- Reliance on licensing agreements.
- Limited brand recognition.
Catalysts
- Upcoming: Potential new licensing agreements for CFQD quantum dots in display applications.
- Ongoing: Expansion of HEATWAVE quantum dots in sensor technology market.
- Ongoing: Development of VIVODOTS nanoparticles for medical imaging.
- Ongoing: Strategic partnerships with leading technology companies to enhance market reach.
Risks
- Potential: Competition from established nanomaterial companies.
- Potential: Technological obsolescence in the rapidly evolving semiconductor industry.
- Ongoing: Negative profitability and reliance on licensing agreements for revenue.
- Potential: Economic downturns affecting demand for display and sensor products.
Growth Opportunities
- Expansion in Display Technology: Nanoco can capitalize on the growing demand for quantum dot displays in TVs, monitors, and mobile devices. The quantum dot display market is projected to reach $34.1 billion by 2028. Nanoco's CFQD quantum dots offer superior color performance and energy efficiency, providing a competitive advantage. Timeline: Ongoing.
- Sensor Applications: The market for quantum dot-based sensors is expanding, driven by applications in environmental monitoring, industrial automation, and medical diagnostics. The global sensor market is expected to reach $278.7 billion by 2029. Nanoco's HEATWAVE quantum dots can be used to develop highly sensitive and accurate sensors. Timeline: Ongoing.
- Medical Imaging: Nanoco's VIVODOTS nanoparticles have potential applications in medical imaging and diagnostics. The medical imaging market is projected to reach $52.98 billion by 2029. These nanoparticles can be used to enhance the contrast and resolution of medical images, improving diagnostic accuracy. Timeline: Ongoing.
- Licensing Agreements: Nanoco can generate revenue through licensing its quantum dot technology to display manufacturers, sensor developers, and medical device companies. Licensing agreements provide a recurring revenue stream and allow Nanoco to expand its market reach without significant capital investment. Timeline: Ongoing.
- Strategic Partnerships: Collaborating with leading technology companies can accelerate the adoption of Nanoco's quantum dot technology. Strategic partnerships can provide access to new markets, distribution channels, and technical expertise. Forming alliances with key players in the display, sensor, and medical industries can enhance Nanoco's competitive position. Timeline: Ongoing.
Opportunities
- Expansion in display technology market.
- Growth in sensor applications.
- Development of new medical imaging solutions.
- Strategic partnerships with leading technology companies.
Threats
- Competition from established nanomaterial companies.
- Technological obsolescence.
- Economic downturns affecting demand for display and sensor products.
- Regulatory changes impacting the use of nanomaterials.
Competitive Advantages
- Proprietary technology in quantum dot development and manufacturing.
- Strong patent portfolio protecting its nanomaterial innovations.
- Established relationships with key players in the display and sensor industries.
About NNOCF
Nanoco Group plc, founded in 2001 and based in Runcorn, UK, focuses on the research, development, manufacture, and licensing of novel nanomaterials. Originally named Evolutec Group plc, the company rebranded as Nanoco Group plc in 2009. Its core product is CFQD quantum dots, fluorescent semiconductor nanoparticles used in OLED and µLED color conversion, QD-EL, and security tagging. Additionally, Nanoco offers HEATWAVE quantum dots for sensor applications and VIVODOTS nanoparticles for medical and veterinary uses. The company operates globally, with a presence in the United Kingdom, Japan, Singapore, Holland, France, Taiwan, Canada, Saudi Arabia, and the United States. Nanoco licenses its technology and manufactures nanomaterials, positioning itself as a key player in the advanced materials sector.
What They Do
- Researches and develops novel nanomaterials.
- Manufactures CFQD quantum dots for display applications.
- Produces HEATWAVE quantum dots for sensor technology.
- Creates VIVODOTS nanoparticles for medical and veterinary uses.
- Licenses its nanomaterial technology to various industries.
- Operates in the United Kingdom, Japan, Singapore, and other international markets.
Business Model
- Develops and manufactures quantum dots and other nanomaterials.
- Licenses its technology to companies in the display, sensor, and medical industries.
- Generates revenue through licensing fees and material sales.
Industry Context
Nanoco Group plc operates within the semiconductor industry, specifically focusing on nanomaterials and quantum dots. The industry is characterized by rapid technological advancements and intense competition. Market trends include the increasing demand for energy-efficient displays, advanced sensor technologies, and medical imaging solutions. Nanoco competes with companies developing similar nanomaterials and display technologies. The company's success depends on its ability to innovate and secure licensing agreements in this dynamic market.
Key Customers
- Display manufacturers seeking to improve color performance and energy efficiency.
- Sensor developers requiring highly sensitive and accurate sensing materials.
- Medical device companies looking to enhance medical imaging and diagnostics.
- Security companies using quantum dots for tagging and anti-counterfeiting measures.
Financials
Chart & Info
Nanoco Group plc (NNOCF) stock price: Price data unavailable
Latest News
No recent news available for NNOCF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NNOCF.
Price Targets
Wall Street price target analysis for NNOCF.
MoonshotScore
What does this score mean?
The MoonshotScore rates NNOCF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Liam Frederick Gray
CEO
Liam Frederick Gray serves as the CEO of Nanoco Group plc, managing a team of 47 employees. His background includes extensive experience in the technology sector, with a focus on nanomaterials and advanced materials. Gray has held various leadership positions in research and development, business development, and strategic planning. He is responsible for driving Nanoco's growth strategy, overseeing its operations, and managing its relationships with key stakeholders.
Track Record: Under Liam Frederick Gray's leadership, Nanoco Group plc has focused on expanding its licensing agreements and developing new applications for its quantum dot technology. Key milestones include securing partnerships with leading display manufacturers and expanding its presence in the sensor and medical imaging markets. Gray has also overseen the company's efforts to strengthen its patent portfolio and protect its intellectual property.
NNOCF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Nanoco Group plc may not meet the minimum financial or regulatory requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure and may be subject to greater risks due to less stringent listing standards compared to exchanges like NYSE or NASDAQ. Investors should exercise caution and conduct thorough due diligence before investing in OTC Other stocks.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure.
- Low trading volume and liquidity.
- Potential for price volatility.
- Higher risk of fraud or manipulation.
- Less regulatory oversight compared to listed exchanges.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Check for any legal or regulatory issues.
- Review the company's investor relations materials.
- Consult with a financial advisor.
- Understand the risks associated with OTC investing.
- Established operations in multiple countries.
- Patent portfolio protecting its technology.
- Licensing agreements with reputable companies.
- Experienced management team.
- Presence in the nanomaterials sector.
Common Questions About NNOCF
What does Nanoco Group plc do?
Nanoco Group plc specializes in the research, development, manufacture, and licensing of quantum dots and other nanomaterials. These materials are primarily used in display technologies, sensor applications, and medical imaging. The company's business model revolves around creating innovative nanomaterials and licensing these technologies to manufacturers in various industries, generating revenue through licensing fees and material sales. Nanoco operates globally, serving customers in the display, sensor, and medical device markets.
What do analysts say about NNOCF stock?
As of 2026-03-17, there is no readily available analyst consensus on NNOCF stock due to its OTC listing and limited coverage. Key valuation metrics such as P/E ratio (-4.83) and profit margin (-28.8%) reflect the company's current financial challenges. Growth considerations include the potential for increased licensing revenue and expansion into new markets. Investors should conduct their own due diligence and consider the risks associated with OTC stocks before making any investment decisions.
What are the main risks for NNOCF?
The main risks for Nanoco Group plc include competition from established nanomaterial companies, technological obsolescence in the rapidly evolving semiconductor industry, and reliance on licensing agreements for revenue. The company's negative profitability and small market capitalization also pose financial risks. Additionally, as an OTC-listed stock, NNOCF is subject to greater price volatility and liquidity constraints compared to stocks listed on major exchanges. Investors should carefully consider these risks before investing in NNOCF.
What are the key factors to evaluate for NNOCF?
Nanoco Group plc (NNOCF) currently holds an AI score of 48/100, indicating low score. Key strength: Proprietary quantum dot technology.. Primary risk to monitor: Potential: Competition from established nanomaterial companies.. This is not financial advice.
How frequently does NNOCF data refresh on this page?
NNOCF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven NNOCF's recent stock price performance?
Recent price movement in Nanoco Group plc (NNOCF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Proprietary quantum dot technology.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider NNOCF overvalued or undervalued right now?
Determining whether Nanoco Group plc (NNOCF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying NNOCF?
Before investing in Nanoco Group plc (NNOCF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC market data may be limited or delayed.
- AI analysis is pending and may provide additional insights.